Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Atrial Fibrillation: In Search for the Optimal Target for Rate Control [Phase 4]
Phase 4 study from The University of Hong Kong investigating the optimal rate-control target for atrial fibrillation and currently not yet r…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation [Phase 3]
Phase 3 trial of Vein of Marshall ethanol infusion for persistent atrial fibrillation completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Characterising the Stable and Dynamic Left Atrial Substrate in Atrial Fibrillation [NA]
This ClinicalTrials.gov update reports the completion and posting of results for a study characterising the stable and dynamic left atrial s…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Stepwise Strategy for Treatment of Atrialfibrillation Substrate Study
Clinical trial update on a stepwise strategy for treating atrial fibrillation substrate; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Exercise Training to Atrial Fibrillation [NA]
This document is a clinical trial update about an exercise training program for atrial fibrillation, with the study currently active but not…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillation - Trigger and Substrate Guided Wide Area Radiofrequency Ablation Compared to Pulsed Field Ablation Pulmonary Vein Isolation [NA]
Clinical trial update describing a randomized comparison between trigger- and substrate-guided wide-area radiofrequency ablation and pulsed-…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery [Phase 3]
Phase 3 trial evaluating magnesium sulfate for prevention of atrial fibrillation after cardiac surgery; the study is completed and results w…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Incidence and Predictors of Recurrent Stroke in Cryptogenic Stroke Patients With Atrial Fibrillation
This clinical trial update reports on the incidence of recurrent ischemic stroke and the factors that predict recurrence in patients with cr…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device [NA]
Clinical trial evaluating the safety and performance of the ENDOMATIC SEPIOLA left atrial appendage closure device for atrial fibrillation i…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation [Phase 3]
Phase 3 clinical trial evaluated the safety and effectiveness of a multi-electrode radiofrequency balloon catheter for treating symptomatic …
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Inflammation and Postoperative Atrial Fibrillation in Cardiac Surgery
Odense University Hospital is actively recruiting for a clinical trial investigating the relationship between inflammation and postoperative…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study [NA]
This clinical trial update describes a study on correlating arrhythmia mechanisms and substrate to ablate persistent atrial fibrillation, cu…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF
A clinical trial evaluating Apple Watch surveillance to reliably assess recurrence burden in surgically treated atrial fibrillation; current…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure [NA]
A Yonsei University study is evaluating beta-blockers to prevent supraventricular arrhythmias after patent foramen ovale (PFO) closure; the …
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Evaluation of YouControl-AFib, a mHealth Application for Persons With Atrial Fibrillation [NA]
The update reports the completion of a clinical trial evaluating YouControl-AFib, a mobile health application for people with atrial fibrill…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation [Phase 4]
Phase 4 study evaluating intensive management of blood pressure and cholesterol in elderly Chinese patients with hypertension and atrial fib…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial [Phase 3]
A Phase 3 pilot trial is evaluating short-term anti-arrhythmic therapy to prevent post-operative atrial fibrillation in cardiac surgery pati…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Arrhythmias in Post-Myocardial Infarction Patients
A clinical trial evaluating arrhythmias in patients after myocardial infarction has completed. The snippet notes the status but does not pro…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Super-Rehab: a Novel Approach to Treat Atrial Fibrillation [NA]
A clinical trial update describing Super-Rehab, a novel approach to treating atrial fibrillation with overweight/obesity as a comorbidity; t…
-
FDA approval · 2025-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Diltiazem Hydrochloride by Alembic Pharmaceuticals Inc. The action represents a supplemental reg…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Future Cardia™ Insertable Cardiac Monitor in Subjects With Paroxysmal Atrial Fibrillation (First-in-Human Study) [NA]
This update reports a first-in-human study of Future Cardia's insertable cardiac monitor for paroxysmal atrial fibrillation; the trial is cu…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Marshall Vein Ethanol Infusion in Addition to Pulsed Electric Field Ablation Versus Pulsed Electric Field Ablation Alone for Paroxysmal Atrial Fibrillation [NA]
This clinical trial update shows recruitment ongoing for a study evaluating Vein of Marshall ethanol infusion in addition to Pulsed Electric…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland
A registry study in Poland evaluating pulsed field ablation for atrial arrhythmias (atrial fibrillation, atrial flutter, and atrial tachycar…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Landiolol in Postoperative Atrial Fibrillation [Phase 3]
Phase 3 trial of landiolol for postoperative atrial fibrillation has completed.
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Predicting Development of SCAF in Device Patients
This clinical trial update shows a study aiming to predict the development of subclinical atrial fibrillation (SCAF) in patients with cardia…